UC Irvine biologists, chemists and computer scientists have identified an elusive pocket on the surface of the p53 protein that can be targeted by cancer-fighting drugs. The finding heralds a new treatment approach, as mutant forms of this protein are implicated in nearly 40 percent of diagnosed cases of cancer, which kills more than half a million Americans each year.
Experimental vaccine trains immune system to target remaining tumor cells after surgery, chemo
Experiemental vaccines hold promise to slow the return of glioblastoma multiforme. UC Irvine begins enrolling patients in DCVax trial.
Researchers with UC Irvine’s Chao Family Comprehensive Cancer Center have identified a genetic pathway in melanoma cells that inhibits the cellular mechanism for detecting DNA damage wrought by chemotherapy, thereby building up tolerance to cancer-killing drugs.
Collaboration that allows students and community members to train with professionals is rare, says organizer Jodie Gates.
Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option that lengthens their lives, according a study led by UCI oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group.
UCI neuroscientist will helm quarterly publication featuring original research in basic science, translational research and clinical studies.
Orange County’s preeminent breast health center joins forces with UC Irvine, which will provide access to comprehensive cancer center and clinical trials.
Artist treated at UC Irvine Medical Center plans to be among the 30 percent who beat the odds.
The clinical professor and director of medical physics in UC Irvine’s Department of Radiation Oncology and at the Chao Family Comprehensive Cancer Center is one of 39 people nationwide selected as Educators of the Year.